Is riluzole a new drug for Alzheimer's disease?

Research output: Contribution to journalEditorial (Academic Journal)peer-review

9 Citations (Scopus)
359 Downloads (Pure)


This Editorial highlights a study by Hunsberger et al. (2015) in the current issue of Journal of Neurochemistry, in which the authors explore the effects of riluzole (R) treatment on tau-P301L transgenic mice. The authors employed a comprehensive analysis of possible restorative effects of the drug by examining glutamate levels in subregions of the hippocampus, expression of tau and its hyper-phosphorylated forms, and memory function using behavioral tests. The authors report a simultaneous reduction in glutamate reuptake and an increase in glutamate release in the tau-P301L model, both of which are ameliorated with riluzole treatment. The authors' findings have implications for our understanding of synaptic transmission mechanisms also associated with Alzheimer's disease pathology.

Original languageEnglish
Pages (from-to)207-209
Number of pages3
JournalJournal of Neurochemistry
Issue number2
Early online date7 Sept 2015
Publication statusPublished - 9 Oct 2015


  • Alzheimer's disease (AD)
  • riluzole
  • tau
  • glutamate transporter
  • PSD-95
  • hyperexcitability


Dive into the research topics of 'Is riluzole a new drug for Alzheimer's disease?'. Together they form a unique fingerprint.

Cite this